Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease

Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease

Despite the evolution in inflammatory bowel disease (IBD) management during the last 20 years owing to the advent of new advanced therapies, anti-TNF agents still remain the cornerstone of therapy for both Crohn’s disease and ulcerative colitis. However, this does not only secure favorable outcomes...

Full description

Bibliographic Details
Main Authors: Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Eirini Theodoraki, Ioannis E. Koutroubakis
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Clinical Medicine
Subjects:
biologics
Crohn’s disease
immunomodulators
therapeutic drug monitoring
ulcerative colitis
Online Access:https://www.mdpi.com/2077-0383/12/7/2452

Similar Items

Similar Items